WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Ayala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-06 2:49 pm Sale |
2022-12-30 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
WELLINGTON MANAGEMENT CO LLP | 0 0.000% |
-710,235 (Position Closed) |
Filing |
| 2022-02-04 09:15 am Sale |
2021-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
WELLINGTON MANAGEMENT CO LLP | 710,235 5.100% |
-45,120 (-5.97%) |
Filing |
| 2021-02-03 2:14 pm Purchase |
2020-12-31 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
WELLINGTON MANAGEMENT CO LLP | 755,355 5.910% |
755,355 (New Position) |
Filing |